Precigen Stock

Precigen Employees 2024

Precigen Employees

770

Ticker

PGEN

ISIN

US74017N1054

WKN

A2PZG1

In 2024, Precigen employed 770 people, a 0% change from the 770 number of employees in the previous year.

Precigen Aktienanalyse

What does Precigen do?

Precigen Inc is a biotechnology company headquartered in Germantown, Maryland, USA. The company was founded in 1991 under the name Human Genome Sciences Inc and became the first company in the industry to unlock genetic genes for drug development. In 2019, the company was renamed Precigen Inc. The company specializes in the development of cell and gene therapy products based on the latest advances in regenerative medicine. The goal is to treat diseases that have been difficult or even considered incurable through gene therapy, genome sequencing, and artificial intelligence. Precigen is divided into several divisions: Precigen ActoBio, Precigen Genome, Precigen RegenX, and Precigen Triple Gem. The divisions differ in product development and target application areas. Precigen ActoBio focuses on the development of biological therapies for autoimmune diseases. The company is working on an oral immunotherapy that can treat respiratory and inflammatory bowel diseases. The product is in the testing phase and if all goes well, approval could be within reach. Precigen Genome specializes in genome sequencing. The data from the genes is decoded to develop better medical diagnoses and therapies. Precigen Genome's services range from sequencing genomic information to uncovering further details to interpreting genome data. Precigen RegenX develops gene therapy products for the treatment of rare but severe genetic diseases. The aim is to modify specific genes in the body to achieve a cure or alleviate symptoms. An example of a product from Precigen RegenX is a gene therapy for hemophilia. This product is being tested in phase II clinical trials and could represent a true revolution in treatment. Precigen Triple Gem is the company's newest division, founded in 2020. It is a research and development project focused on novel cancer therapies. The main focus is on the development of CAR-T cells that can recognize and destroy various types of cancer cells. The company has already achieved promising results. The products from Precigen aim to simplify the treatment of severe diseases and minimize side effects through integration into molecular medicine. Patient safety is the top priority. To ensure this, strict testing phases are undergone and there is close monitoring of product development. Precigen's business strategy is based on collaboration with other companies and institutions. The company works with large pharmaceutical companies to support production, distribution, and marketing of the products, among other partnerships. Another important partnership is with universities and research institutions, which help the company in developing new technologies, improving production processes, and conducting clinical trials. This collaboration leads to faster research insights and a larger pool of knowledge and know-how. Precigen is also committed to recruiting the best talent and qualified personnel in the field of biotechnology. Overall, Precigen is an extremely innovative and promising company in the field of regenerative medicine and gene therapy. The company relies on a clever business strategy and forward-thinking partnerships to develop even better therapies for serious, previously incurable diseases in the future. Precigen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Precigen's Employee Base

Precigen's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Precigen's operational capacity and future potential.

Year-to-Year Comparison

Assessing Precigen's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Precigen's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Precigen’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Precigen stock

How many employees does Precigen have this year?

Precigen has 770 undefined employees this year.

How many employees did Precigen have compared to the previous year?

Compared to the previous year, Precigen had 0% more employees.

What impact did the number of employees have on the company Precigen?

The number of employees has a direct impact on the efficiency and productivity of Precigen. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Precigen?

The number of employees can also have an impact on investors of Precigen, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Precigen affect the company?

An increase in equity of Precigen can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Precigen's equity affect the company?

A reduction in equity of Precigen can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Precigen?

Some factors that can influence the equity of Precigen include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Precigen so important for investors?

The equity of Precigen is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Precigen influence the company?

The number of employees at Precigen can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Precigen evolved in recent years?

In recent years, the number of employees at Precigen has changed by 0.

How many employees does Precigen currently have?

Precigen currently has 770 undefined employees.

Why is the number of employees important for investors of Precigen?

The number of employees is important for investors of Precigen as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Precigen take to change the number of employees?

To change the number of employees, Precigen can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Precigen pay?

Over the past 12 months, Precigen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Precigen is expected to pay a dividend of 0 USD.

What is the dividend yield of Precigen?

The current dividend yield of Precigen is .

When does Precigen pay dividends?

Precigen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Precigen?

Precigen paid dividends every year for the past 0 years.

What is the dividend of Precigen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Precigen located?

Precigen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Precigen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Precigen from 7/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Precigen pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Precigen in the year 2023?

In the year 2023, Precigen distributed 0 USD as dividends.

In which currency does Precigen pay out the dividend?

The dividends of Precigen are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Precigen

Our stock analysis for Precigen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precigen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.